The HSP90 family are molecular chaperones that regulate the stability of several proteins involved in tumor development (including KIT and PDGFRA); therefore, inhibition of HSP90 with pimitespib may represent an alternative treatment strategy to TKIs [15, 16]. The gene discussed is KIT; the disease is neoplasm.